|
Archived News |
NYBA News |
Press Release
|
| |
|
|
Pharmaceutical Research and Manufacturers of America (PhRMA) |
|
Headline:
Nearly 300 Medicines in Development to Meet Unique Needs of Children
Date:
13-Jan-2012
News Type:
Member News
...
Details »
|
|
| |
|
Amgen, Inc. |
|
Headline:
Amgen and FDA Agree to Modify Nplate® (Romiplostim) Risk Evaluation and Mitigation Strategy
Date:
06-Dec-2011
News Type:
Member News
Prescribing Physicians, Patients and Institutions no Longer Required to Enroll in Nplate® NEXUS Program
...
Details »
|
|
| |
|
Regeneron Pharmaceuticals, Inc. |
|
Headline:
Two Year Results of Phase 3 Studies with EYLEA(TM) (aflibercept) Injection in wet AMD Show Sustained Improvement in Visual Acuity
Date:
05-Dec-2011
News Type:
Member News
Two Year Results of Phase 3 Studies with EYLEA™ (af ...
Details »
|
|
| |
|
Pfizer Inc. |
|
Headline:
Pfizer’s Toviaz Shows Positive Top-Line Primary Endpoint Result In Study Of Overactive Bladder In Vulnerable Elderly Patients
Date:
05-Dec-2011
News Type:
Member News
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today the top-line primary endpoint result for Toviaz (fesoterodine fumarate) Study A0221049 ...
Details »
|
|
| |
|
Pfizer Inc. |
|
Headline:
Pfizer Completes Acquisition of Excaliard
Date:
02-Dec-2011
News Type:
Member News
NEW YORK--(BUSINESS WIRE)--Pfizer Inc. (NYSE: PFE) announced today that it has completed its acquisition of Excaliard Pharmaceuticals, Inc., a privately owned biopharmaceu ...
Details »
|
|
| |
|
Bristol-Myers Squibb Company |
|
Headline:
Bristol-Myers Squibb Enters Clinical Collaboration Agreement with Tibotec Pharmaceuticals for Phase II Combination Study in Patients Chronically Infected with Hepatitis C
Date:
02-Dec-2011
News Type:
Member News
NEW YORK--(BUSINESS WIRE)--Bristol-Myers Squibb Company (NYSE:BMY) announced today that it has entered int ...
Details »
|
|
| |
|
Genentech Inc. |
|
Headline:
Genentech to Present Important New Data for HER2-Positive Breast Cancer at 2011 San Antonio Breast Cancer Symposium
Date:
29-Nov-2011
News Type:
Member News
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), today announced the company will present results from studies of its investigational medicine pertuzumab in HER2 ...
Details »
|
|
| |
|
Regeneron Pharmaceuticals, Inc. |
|
Headline:
Regeneron and Bayer Initiate Phase 3 Clinical Program for the Treatment of Wet Age-Related Macular Degeneration in China
Date:
28-Nov-2011
News Type:
Member News
...
Details »
|
|
| |
|
Amgen, Inc. |
|
Headline:
Enbrel® (etanercept) Patent Issued
Date:
22-Nov-2011
News Type:
Member News
Amgen today announced the issuance of U.S. Patent No. 8,063,182 related to Enbrel® (etanercept). This patent is owned by Hoffman-La Roche Inc. ("Roche") and exclusively licensed to Amg ...
Details »
|
|
| |
|
Regeneron Pharmaceuticals, Inc. |
|
Headline:
Regeneron Announces FDA Acceptance of ARCALYST® (rilonacept) Supplemental Biologics License Application for Review
Date:
22-Nov-2011
News Type:
Member News
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) today announced that the U.S. Food and Drug Admi ...
Details »
|
|
| |
|
|
